Miyuki Niimi

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. pmc Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer
    Tomonori Yano
    Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
    Radiat Oncol 7:113. 2012
  2. pmc Design paper: a phase II study of bevacizumab and erlotinib in patients with non-squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous treatment (BEST)
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyoku, Kyoto 606 8507, Japan
    Trials 12:120. 2011

Detail Information

Publications2

  1. pmc Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer
    Tomonori Yano
    Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
    Radiat Oncol 7:113. 2012
    ..This study was undertaken to clarify the optimum laser fluence rate of PDT using talaporfin sodium and a diode laser for patients with local failure after CRT or radiotherapy (RT) for esophageal cancer...
  2. pmc Design paper: a phase II study of bevacizumab and erlotinib in patients with non-squamous non-small cell lung cancer that is refractory or relapsed after 1-2 previous treatment (BEST)
    Shiro Tanaka
    Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyoku, Kyoto 606 8507, Japan
    Trials 12:120. 2011
    ..We are conducting a single arm phase II trial which aims to evaluate the efficacy and safety of this regime as a second- or third-line chemotherapy...